J Alejandro Rauh-Hain
Overview
Explore the profile of J Alejandro Rauh-Hain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
113
Citations
1595
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adjuvant Chemoradiotherapy vs Radiotherapy Alone for Patients With Intermediate-Risk Cervical Cancer
Agusti N, Viveros-Carreno D, Wu C, Wilke R, Kanbergs A, Barajas K, et al.
JAMA Oncol
. 2025 Mar;
PMID: 40079948
Importance: Optimal adjuvant treatment for patients with intermediate-risk cervical cancer remains controversial, and the benefit of adding chemotherapy to radiotherapy in this population is uncertain. Objective: To evaluate whether adjuvant...
2.
Rauh-Hain J, Melamed A, Pareja R, May T, Sinno A, McNally L, et al.
JAMA Netw Open
. 2024 Nov;
7(11):e2446325.
PMID: 39570589
Importance: Despite the absence of high-quality evidence of its safety and effectiveness, minimally invasive surgery (MIS) is increasingly used to treat advanced epithelial ovarian cancer (EOC). Objective: To assess the...
3.
Bercow A, Stewart T, Bregar A, Gockley A, Mazina V, Rauh-Hain J, et al.
JAMA Netw Open
. 2024 Oct;
7(10):e2439893.
PMID: 39412808
No abstract available.
4.
Bednar E, Wilke R, Jorgensen K, Walsh Jr M, Nutt S, Lu K, et al.
J Community Genet
. 2024 Oct;
15(6):681-686.
PMID: 39397225
Objective: Clinical cancer genetics services are expanding globally, but national policy and health care systems influence availability and implementation. Understanding the environmental factors within a country is required to appropriately...
5.
Kanbergs A, Rauh-Hain J, Wilke R
Clin Obstet Gynecol
. 2024 Sep;
67(4):666-671.
PMID: 39331025
Up to 14% of endometrial cancers and 23% of epithelial ovarian cancers are associated with genetic predispositions. Referral for genetic testing and counseling can significantly impact a patient's oncologic outcomes....
6.
Viveros-Carreno D, Agusti N, Wu C, Melamed A, Wilke R, Kanbergs A, et al.
Obstet Gynecol
. 2024 Sep;
145(1):99-107.
PMID: 39326049
Objective: To assess the effect on overall survival of simple hysterectomy with lymph node staging compared with radical hysterectomy with lymph node staging for patients with early-stage cervical cancer. Methods:...
7.
Bercow A, Carmen M, Rauh-Hain J, Melamed A
J Clin Oncol
. 2024 Jun;
42(23):2731-2735.
PMID: 38917386
Journal Journal of Clinical Oncology
8.
Wilke R, Bednar E, Pirzadeh-Miller S, Lahiri S, Scarinci I, Leath Iii C, et al.
Fam Cancer
. 2024 May;
23(2):141-145.
PMID: 38748383
The Precision Medicine Initiative was launched upon the potential of genomic information to tailor medical care. Cascade genetic testing represents a powerful application of precision medicine and involves the process...
9.
Huang Y, Rauh-Hain J, McCoy T, Hou J, Hillyer G, Ferris J, et al.
Gynecol Oncol
. 2024 Mar;
186:9-16.
PMID: 38554626
Objective: To develop and evaluate a multidimensional comorbidity index (MCI) that identifies ovarian cancer patients at risk of early mortality more accurately than the Charlson Comorbidity Index (CCI) for use...
10.
Pham T, Lapid D, Schmeler K, Rauh-Hain J, Leon M
Case Rep Oncol
. 2023 Nov;
16(1):1274-1279.
PMID: 37928866
A 38-year-old female with an etonogestrel implant in place and history of previous ectopic pregnancy presented with acute abdominal pain and vaginal bleeding. She was found to have a beta-hCG...